Andrew Godley
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Andrew Godley has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
- Steve Jiang
University of Texas Southwestern Medical Center
5 shared publications - Bin Cai
Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
4 shared publications - Robert Timmerman
Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
4 shared publications - Arnold Pompos
Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
3 shared publications - Aurelie Garant
Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
3 shared publications - David Parsons
Department of Radiation Oncology University of Texas Southwestern Medical Center Dallas Texas USA
3 shared publications
Latest Publications
- Open Access
- 18 December 2025
- Published by MDPI AG in Healthcare
- Vol. 13 (24) , 3315
Medical Physics Adaptive Radiotherapy (MPART) Fellowship: Bridging the Training Gap in Online Adaptive Radiotherapy
Online adaptive radiotherapy (ART) is rapidly transforming clinical radiation oncology by enabling adaptation of treatment plans based on patient-specific anatomical and biological changes. However, most medical physics training programs lack structured education in ART. To address this critical gap, the Medical Physics Adaptive Radiotherapy (MPART) Fellowship was established at our center to train post-residency or practicing physicists in advanced adaptive technologies and workflows. The MPART Fellowship is a two-year program that provides immersive, platform-specific training in CBCT-guided (Varian Ethos), MR-guided (Elekta Unity), and PET-guided (RefleXion X1) radiotherapy. Fellows undergo modular clinical rotations, hands-on training, and dedicated research projects. The curriculum incorporates competencies in imaging, contouring, online planning, quality assurance, and team-based decision-making. Evaluation is based on the Accreditation Council for Graduate Medical Education competency domains and includes milestone tracking, mentor reviews, and structured presentations. The fellowship attracted applicants from both domestic and international institutions, reflecting strong demand for formal ART training. Out of 22 applications, two fellows have been successfully recruited into the program since 2024. Fellows actively participate in all phases of adaptive workflows and are expected to function at near-attending levels by the second year of their training. Each fellow also leads at least one translational or operational research project aimed at improving ART delivery. Fellows contribute to clinical coverage and lead developmental projects, resulting in presentations and publications at the national and international levels. The MPART Fellowship addresses a vital educational need by equipping medical physicists with the advanced competencies necessary for implementing and leading ART. This program offers a replicable framework for other institutions seeking to advance precision radiation therapy through structured post-residency training in adaptive radiotherapy. As this fellowship program is still in its early phase of establishment, the primary goal of this paper is to introduce the structure, framework, and implementation model of the program. Comprehensive outcome analyses—such as quantitative assessments, fellow feedback, and longitudinal competency evaluations—will be incorporated in future work as additional cohorts complete training.
- 18 December 2025
- Published by MDPI AG in Healthcare
- Vol. 13 (24) , 3315
Open AccessMedical Physics Adaptive Radiotherapy (MPART) Fellowship: Bridging the Training Gap in Online Adaptive Radiotherapy
Online adaptive radiotherapy (ART) is rapidly transforming clinical radiation oncology by enabling adaptation of treatment plans based on patient-specific anatomical and biological changes. However, most medical physics training programs lack structured education in ART. To address this critical gap, the Medical Physics Adaptive Radiotherapy (MPART) Fellowship was established at our center to train post-residency or practicing physicists in advanced adaptive technologies and workflows. The MPART Fellowship is a two-year program that provides immersive, platform-specific training in CBCT-guided (Varian Ethos), MR-guided (Elekta Unity), and PET-guided (RefleXion X1) radiotherapy. Fellows undergo modular clinical rotations, hands-on training, and dedicated research projects. The curriculum incorporates competencies in imaging, contouring, online planning, quality assurance, and team-based decision-making. Evaluation is based on the Accreditation Council for Graduate Medical Education competency domains and includes milestone tracking, mentor reviews, and structured presentations. The fellowship attracted applicants from both domestic and international institutions, reflecting strong demand for formal ART training. Out of 22 applications, two fellows have been successfully recruited into the program since 2024. Fellows actively participate in all phases of adaptive workflows and are expected to function at near-attending levels by the second year of their training. Each fellow also leads at least one translational or operational research project aimed at improving ART delivery. Fellows contribute to clinical coverage and lead developmental projects, resulting in presentations and publications at the national and international levels. The MPART Fellowship addresses a vital educational need by equipping medical physicists with the advanced competencies necessary for implementing and leading ART. This program offers a replicable framework for other institutions seeking to advance precision radiation therapy through structured post-residency training in adaptive radiotherapy. As this fellowship program is still in its early phase of establishment, the primary goal of this paper is to introduce the structure, framework, and implementation model of the program. Comprehensive outcome analyses—such as quantitative assessments, fellow feedback, and longitudinal competency evaluations—will be incorporated in future work as additional cohorts complete training.
- Open Access
A Clinical Workflow for Evaluating Dose to Organs at Risk After Biology-Guided Radiation Therapy Delivery
Purpose: To develop a workflow for systemically reviewing the doses received by organs at risk (OARs) in a BgRT treatment session, as a means of monitoring delivery constancy and possibly identifying changes of clinical concern in the patient. Methods: We implemented a workflow consisting of a qualitative review of the reconstructed delivered-dose information provided by the RefleXion system, followed by its quantitative evaluation using in-house software. For the latter we developed a framework for calculating custom OAR dose–volume metrics from the delivered-dose distribution and graphing them. We retrospectively applied our workflow to three select BgRT patient cases to appraise its clinical utility. Results: Our workflow efficiently incorporates existing RefleXion TPS features and in-house software into a process for thoroughly evaluating doses to OARs after BgRT delivery. The spreadsheet we created for graphing the trends of normalized OAR dose–volume metrics readily shows if OAR doses have significantly changed or tolerance limits have been violated, thereby potentially revealing if changes of concern occurred in the targeted region. Our workflow also yields a cumulative delivered-dose record at the end of treatment. Conclusions: We established a post-BgRT dose evaluation workflow which supplements the information provided by RefleXion with calculation and graphing of custom OAR dose–volume metrics. This workflow is now routinely used in our clinic following all BgRT treatments. Future improvements could include increased automation, updating the dose calculation to reflect changes in patient anatomy, incorporation of PET metrics, and consideration of target dose data.
Open AccessA Clinical Workflow for Evaluating Dose to Organs at Risk After Biology-Guided Radiation Therapy Delivery
Purpose: To develop a workflow for systemically reviewing the doses received by organs at risk (OARs) in a BgRT treatment session, as a means of monitoring delivery constancy and possibly identifying changes of clinical concern in the patient. Methods: We implemented a workflow consisting of a qualitative review of the reconstructed delivered-dose information provided by the RefleXion system, followed by its quantitative evaluation using in-house software. For the latter we developed a framework for calculating custom OAR dose–volume metrics from the delivered-dose distribution and graphing them. We retrospectively applied our workflow to three select BgRT patient cases to appraise its clinical utility. Results: Our workflow efficiently incorporates existing RefleXion TPS features and in-house software into a process for thoroughly evaluating doses to OARs after BgRT delivery. The spreadsheet we created for graphing the trends of normalized OAR dose–volume metrics readily shows if OAR doses have significantly changed or tolerance limits have been violated, thereby potentially revealing if changes of concern occurred in the targeted region. Our workflow also yields a cumulative delivered-dose record at the end of treatment. Conclusions: We established a post-BgRT dose evaluation workflow which supplements the information provided by RefleXion with calculation and graphing of custom OAR dose–volume metrics. This workflow is now routinely used in our clinic following all BgRT treatments. Future improvements could include increased automation, updating the dose calculation to reflect changes in patient anatomy, incorporation of PET metrics, and consideration of target dose data.
- Open Access
- 21 August 2025
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 26 (9) , e70228
Development and clinical implementation of an MRI‐only planning workflow featuring deep learning‐based synthetic CT for prostate cancer external beam radiotherapy
Background: In external beam radiation therapy (EBRT) for prostate cancer, both MRI and CT are typically used—CT provides electron density for dose calculation and visualization of bony anatomy and fiducial markers, while MRI offers superior soft tissue contrast. With recent advances in deep learning, synthetic CT (sCT) images can now be generated from MRI, potentially eliminating the need for separate CT scans. Purpose: To clinically implement an MRI‐only planning (MROP) workflow for both X‐ray and MRI‐guided systems. Methods: MROP implementation involved optimizing MRI simulation protocols, developing a deep learning‐based sCT generation method, and automating fiducial marker detection. A multichannel CycleGAN model was trained using T1‐weighted Dixon images to generate sCT. For SBRT cases, the immobilization device was auto‐inserted into sCT images. Fiducial markers were detected using a quantitative susceptibility mapping (QSM) method. Validation included retrospective comparison of Hounsfield units and dosimetric plans to those based on planning CT for 11 patients, followed by prospective evaluation of ten patients. Results: The MRI protocol included T2‐weighted 3D imaging for contouring, T1‐weighted Dixon for sCT, and T2*‐weighted GRE for fiducial detection. The MROP workflow was prospectively applied in 10 patients (three SBRT, seven conventional). Dosimetric comparisons showed <1% difference between MROP and CT‐based plans across all PTVs. The QSM‐based fiducial detection achieved a 95.5% success rate (63/66 markers) and reduced detection time from ∼10 to 2 min per patient. All MROP components were integrated into the treatment planning system via scripting. Implementation reduced simulation scheduling time by 7.1 days. Conclusion: We successfully implemented an MROP workflow for prostate cancer EBRT, eliminating the need for CT, reducing radiation exposure, and improving clinical efficiency. Over 500 patients have been treated to date using this approach on both C‐arm and MR‐guided systems.
- 21 August 2025
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 26 (9) , e70228
Open AccessDevelopment and clinical implementation of an MRI‐only planning workflow featuring deep learning‐based synthetic CT for prostate cancer external beam radiotherapy
Background: In external beam radiation therapy (EBRT) for prostate cancer, both MRI and CT are typically used—CT provides electron density for dose calculation and visualization of bony anatomy and fiducial markers, while MRI offers superior soft tissue contrast. With recent advances in deep learning, synthetic CT (sCT) images can now be generated from MRI, potentially eliminating the need for separate CT scans. Purpose: To clinically implement an MRI‐only planning (MROP) workflow for both X‐ray and MRI‐guided systems. Methods: MROP implementation involved optimizing MRI simulation protocols, developing a deep learning‐based sCT generation method, and automating fiducial marker detection. A multichannel CycleGAN model was trained using T1‐weighted Dixon images to generate sCT. For SBRT cases, the immobilization device was auto‐inserted into sCT images. Fiducial markers were detected using a quantitative susceptibility mapping (QSM) method. Validation included retrospective comparison of Hounsfield units and dosimetric plans to those based on planning CT for 11 patients, followed by prospective evaluation of ten patients. Results: The MRI protocol included T2‐weighted 3D imaging for contouring, T1‐weighted Dixon for sCT, and T2*‐weighted GRE for fiducial detection. The MROP workflow was prospectively applied in 10 patients (three SBRT, seven conventional). Dosimetric comparisons showed <1% difference between MROP and CT‐based plans across all PTVs. The QSM‐based fiducial detection achieved a 95.5% success rate (63/66 markers) and reduced detection time from ∼10 to 2 min per patient. All MROP components were integrated into the treatment planning system via scripting. Implementation reduced simulation scheduling time by 7.1 days. Conclusion: We successfully implemented an MROP workflow for prostate cancer EBRT, eliminating the need for CT, reducing radiation exposure, and improving clinical efficiency. Over 500 patients have been treated to date using this approach on both C‐arm and MR‐guided systems.
- Open Access
Strategies for Offline Adaptive Biology-Guided Radiotherapy (BgRT) on a PET-Linac Platform
Background/Objectives: This study aims to present a structured clinical workflow for offline adaptive Biology-guided Radiotherapy (BgRT) using the RefleXion X1 PET-linac system, addressing challenges introduced by inter-treatment anatomical and biological changes. Methods: We propose a decision tree offline adaptation framework based on real-time assessments of Activity Concentration (AC), Normalized Target Signal (NTS), and bounded dose-volume histogram (bDVH%) metrics. Three offline strategies were developed: (1) preemptive adaptation for minor changes, (2) partial re-simulation for moderate changes, and (3) full re-simulation for major anatomical or metabolic alterations. Two clinical cases demonstrating strategies 1 and 2 are presented. Results: The preemptive adaptation strategy was applied in a case with early tumor shrinkage, maintaining delivery parameters within acceptable limits while updating contours and dose distribution. In the partial re-Simulation case, significant changes in PET signal necessitated a same-day PET functional modeling session and plan re-optimization, effectively restoring safe deliverability. Both cases showed reduced target volumes and improved OAR sparing without additional patient visits or tracer injections. Conclusions: Offline adaptive workflows for BgRT provide practical solutions to address inter-fractional changes in tumor structure and function. These strategies can help maintain the safety and accuracy of BgRT delivery and support clinical adoption of PET-guided radiotherapy, paving the way for future online adaptive capabilities.
Open AccessStrategies for Offline Adaptive Biology-Guided Radiotherapy (BgRT) on a PET-Linac Platform
Background/Objectives: This study aims to present a structured clinical workflow for offline adaptive Biology-guided Radiotherapy (BgRT) using the RefleXion X1 PET-linac system, addressing challenges introduced by inter-treatment anatomical and biological changes. Methods: We propose a decision tree offline adaptation framework based on real-time assessments of Activity Concentration (AC), Normalized Target Signal (NTS), and bounded dose-volume histogram (bDVH%) metrics. Three offline strategies were developed: (1) preemptive adaptation for minor changes, (2) partial re-simulation for moderate changes, and (3) full re-simulation for major anatomical or metabolic alterations. Two clinical cases demonstrating strategies 1 and 2 are presented. Results: The preemptive adaptation strategy was applied in a case with early tumor shrinkage, maintaining delivery parameters within acceptable limits while updating contours and dose distribution. In the partial re-Simulation case, significant changes in PET signal necessitated a same-day PET functional modeling session and plan re-optimization, effectively restoring safe deliverability. Both cases showed reduced target volumes and improved OAR sparing without additional patient visits or tracer injections. Conclusions: Offline adaptive workflows for BgRT provide practical solutions to address inter-fractional changes in tumor structure and function. These strategies can help maintain the safety and accuracy of BgRT delivery and support clinical adoption of PET-guided radiotherapy, paving the way for future online adaptive capabilities.
- Open Access
Simulation-Omitting and Using Library Patients for Pre-Planning Online Adaptive Radiotherapy (SUPPORT): A Feasibility Study for Spine Stereotactic Ablative Radiotherapy (SAbR) Patients
Treatment planning in the field of radiation therapy has evolved from three-dimensional (3D) planning to inverse planning and, most recently, to personalized adaptive radiotherapy (ART)
Open AccessSimulation-Omitting and Using Library Patients for Pre-Planning Online Adaptive Radiotherapy (SUPPORT): A Feasibility Study for Spine Stereotactic Ablative Radiotherapy (SAbR) Patients
Treatment planning in the field of radiation therapy has evolved from three-dimensional (3D) planning to inverse planning and, most recently, to personalized adaptive radiotherapy (ART)
- Open Access
Multiomics-Based Outcome Prediction in Personalized Ultra-Fractionated Stereotactic Adaptive Radiotherapy (PULSAR)
Objectives: This retrospective study aims to develop a multiomics approach that integrates radiomics, dosiomics, and delta features to predict treatment responses in brain metastasis (BM) patients undergoing PULSAR. Methods: A retrospective study encompassing 39 BM patients with 69 lesions treated with PULSAR was undertaken. Radiomics, dosiomics, and delta features were extracted from both pre-treatment and intra-treatment MRI scans alongside dose distributions. Six individual models, alongside an ensemble feature selection (EFS) model, were evaluated. The classification task focused on distinguishing between two lesion groups based on whether they exhibited a volume reduction of more than 20% at follow-up. Performance metrics, including sensitivity, specificity, accuracy, precision, F1 score, and the area under the receiver operating characteristic (ROC) curve (AUC), were assessed. Results: The EFS model integrated the features from pre-treatment radiomics, pre-treatment dosiomics, intra-treatment radiomics, and delta radiomics. It outperformed six individual models, achieving an AUC of 0.979, accuracy of 0.917, and F1 score of 0.821. Among the top nine features of the EFS model, six features came from post-wavelet transformation and three from original images. Conclusions: The study demonstrated the feasibility of employing a data-driven multiomics approach to predict treatment outcomes in BM patients receiving PULSAR treatment. Integrating multiomics with intra-treatment decision support in PULSAR shows promise for optimizing patient management and reducing the risks of under- or over-treatment.
Open AccessMultiomics-Based Outcome Prediction in Personalized Ultra-Fractionated Stereotactic Adaptive Radiotherapy (PULSAR)
Objectives: This retrospective study aims to develop a multiomics approach that integrates radiomics, dosiomics, and delta features to predict treatment responses in brain metastasis (BM) patients undergoing PULSAR. Methods: A retrospective study encompassing 39 BM patients with 69 lesions treated with PULSAR was undertaken. Radiomics, dosiomics, and delta features were extracted from both pre-treatment and intra-treatment MRI scans alongside dose distributions. Six individual models, alongside an ensemble feature selection (EFS) model, were evaluated. The classification task focused on distinguishing between two lesion groups based on whether they exhibited a volume reduction of more than 20% at follow-up. Performance metrics, including sensitivity, specificity, accuracy, precision, F1 score, and the area under the receiver operating characteristic (ROC) curve (AUC), were assessed. Results: The EFS model integrated the features from pre-treatment radiomics, pre-treatment dosiomics, intra-treatment radiomics, and delta radiomics. It outperformed six individual models, achieving an AUC of 0.979, accuracy of 0.917, and F1 score of 0.821. Among the top nine features of the EFS model, six features came from post-wavelet transformation and three from original images. Conclusions: The study demonstrated the feasibility of employing a data-driven multiomics approach to predict treatment outcomes in BM patients receiving PULSAR treatment. Integrating multiomics with intra-treatment decision support in PULSAR shows promise for optimizing patient management and reducing the risks of under- or over-treatment.
- Open Access
- 10 April 2023
- Published by Elsevier in Physics and Imaging in Radiation Oncology
- Vol. 26, 100438
Evaluation of fan-beam kilovoltage computed tomography image quality on a novel biological-guided radiotherapy platform
- 10 April 2023
- Published by Elsevier in Physics and Imaging in Radiation Oncology
- Vol. 26, 100438
Open AccessEvaluation of fan-beam kilovoltage computed tomography image quality on a novel biological-guided radiotherapy platform
- Open Access
- 8 December 2022
- Published by IOP Publishing in Biomedical Physics & Engineering Express
- Vol. 9 (1) , 015005
Machine characterization and central axis depth dose data of a superficial x-ray radiotherapy unit
Objectives. The purpose of this study is to present data from the clinical commissioning of an Xstrahl 150 x-ray unit used for superficial radiotherapy, Methods. Commissioning tasks included vendor acceptance tests, timer reproducibility, linearity and end-effect measurements, half-value layer (HVL) measurements, inverse square law verification, head-leakage measurements, and beam output calibration. In addition, percent depth dose (PDD) curves were determined for different combinations of filter/kV settings and applicators. Automated PDD water phantom scans were performed utilizing four contemporary detectors: a microDiamond detector, a microSilicon detector, an EDGE detector, and a PinPoint ionization chamber. The measured PDD data were compared to the published values in BJR Supplement 25, Results. The x-ray unit’s mechanical, safety, and radiation characteristics were within vendor-stated specifications. Across sixty commissioned x-ray beams, the PDDs determined in water using solid state detectors were in excellent agreement with the BJR 25 data. For the lower (2 collimator was (−0.7 ± 1.0)%, Conclusions. This study presents machine characterization data collected for clinical use of a superficial x-ray unit. Special focus was placed on utilizing contemporary detectors and techniques for the relative PDD measurements using a motorized water phantom. The results in this study confirm that the aggregate values published in the BJR 25 report still serve as a valid benchmark when comparing data from site-specific measurements, or the reference data for clinical utilization without such measurements, Advances in knowledge. This paper presents comprehensive data from the acceptance and commissioning of a modern kilovoltage superficial x-ray radiotherapy machine. Comparisons between the PDD data measured in this study using different detectors and BJR 25 data are highlighted.
- 8 December 2022
- Published by IOP Publishing in Biomedical Physics & Engineering Express
- Vol. 9 (1) , 015005
Open AccessMachine characterization and central axis depth dose data of a superficial x-ray radiotherapy unit
Objectives. The purpose of this study is to present data from the clinical commissioning of an Xstrahl 150 x-ray unit used for superficial radiotherapy, Methods. Commissioning tasks included vendor acceptance tests, timer reproducibility, linearity and end-effect measurements, half-value layer (HVL) measurements, inverse square law verification, head-leakage measurements, and beam output calibration. In addition, percent depth dose (PDD) curves were determined for different combinations of filter/kV settings and applicators. Automated PDD water phantom scans were performed utilizing four contemporary detectors: a microDiamond detector, a microSilicon detector, an EDGE detector, and a PinPoint ionization chamber. The measured PDD data were compared to the published values in BJR Supplement 25, Results. The x-ray unit’s mechanical, safety, and radiation characteristics were within vendor-stated specifications. Across sixty commissioned x-ray beams, the PDDs determined in water using solid state detectors were in excellent agreement with the BJR 25 data. For the lower (2 collimator was (−0.7 ± 1.0)%, Conclusions. This study presents machine characterization data collected for clinical use of a superficial x-ray unit. Special focus was placed on utilizing contemporary detectors and techniques for the relative PDD measurements using a motorized water phantom. The results in this study confirm that the aggregate values published in the BJR 25 report still serve as a valid benchmark when comparing data from site-specific measurements, or the reference data for clinical utilization without such measurements, Advances in knowledge. This paper presents comprehensive data from the acceptance and commissioning of a modern kilovoltage superficial x-ray radiotherapy machine. Comparisons between the PDD data measured in this study using different detectors and BJR 25 data are highlighted.
- Open Access
- 17 August 2018
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (8) , e0202533
The effects of extra high dose rate irradiation on glioma stem-like cells
Radiation therapy is an integral part of treatment for patients with glioblastoma. New technological advances in linear accelerators have made extra-high dose rate irradiation possible. This shortens patient treatment time significantly compared to standard dose rate irradiation, but the biologic effects of extra high dose rate irradiation are poorly understood. Glioma stem-like cells (GSCs) are resistant to standard radiation and contribute to tumor progression. Here, we assess the therapeutic effect of extra high dose rate vs. standard dose rate irradiation on GSCs. GSCs were exposed to 2, 4 and 6 Gy X-irradiation at dose rates of 4.2 Gy/min or 21.2 Gy/min (400 monitoring units (MU)/min or 2100 MU/min). We analyzed cell survival with cell growth assays, tumorsphere formation assays and colony formation assays. Cell kill and self-renewal were dependent on the total dose of radiation delivered. However, there was no difference in survival of GSCs or DNA damage repair in GSCs irradiated at different dose rates. GSCs exhibited significant G1 and G2/M phase arrest and increased apoptosis with higher doses of radiation but there was no difference between the two dose rates at each given dose. In a GSC-derived preclinical model of glioblastoma, radiation extended animal survival, but there was no difference in survival in mice receiving different dose rates of radiation. We conclude that GSCs respond to larger fractions of radiation, but extra high dose rate irradiation has no significant biologic advantage in comparison with standard dose rate irradiation.
- 17 August 2018
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (8) , e0202533
Open AccessThe effects of extra high dose rate irradiation on glioma stem-like cells
Radiation therapy is an integral part of treatment for patients with glioblastoma. New technological advances in linear accelerators have made extra-high dose rate irradiation possible. This shortens patient treatment time significantly compared to standard dose rate irradiation, but the biologic effects of extra high dose rate irradiation are poorly understood. Glioma stem-like cells (GSCs) are resistant to standard radiation and contribute to tumor progression. Here, we assess the therapeutic effect of extra high dose rate vs. standard dose rate irradiation on GSCs. GSCs were exposed to 2, 4 and 6 Gy X-irradiation at dose rates of 4.2 Gy/min or 21.2 Gy/min (400 monitoring units (MU)/min or 2100 MU/min). We analyzed cell survival with cell growth assays, tumorsphere formation assays and colony formation assays. Cell kill and self-renewal were dependent on the total dose of radiation delivered. However, there was no difference in survival of GSCs or DNA damage repair in GSCs irradiated at different dose rates. GSCs exhibited significant G1 and G2/M phase arrest and increased apoptosis with higher doses of radiation but there was no difference between the two dose rates at each given dose. In a GSC-derived preclinical model of glioblastoma, radiation extended animal survival, but there was no difference in survival in mice receiving different dose rates of radiation. We conclude that GSCs respond to larger fractions of radiation, but extra high dose rate irradiation has no significant biologic advantage in comparison with standard dose rate irradiation.